Quarterly Result4 Aug 2026, 02:12 pm
Alembic Pharmaceuticals declares Q1 FY27 Unaudited Financial Results
AI Summary
Alembic Pharmaceuticals Limited announced its Unaudited Financial Results for the quarter ended June 30, 2026. The Board of Directors approved both consolidated and standalone results, along with the Limited Review Report from the statutory auditors. The filing confirms the declaration of these results following a board meeting held on August 4, 2026. Specific financial figures from the P&L tables are not included as per instructions, but the declaration of unaudited results for the specified period is the key event.
Key Highlights
- Alembic Pharmaceuticals declared its Q1 FY27 unaudited financial results.
- Both consolidated and standalone results were approved by the Board.
- The Limited Review Report from statutory auditors was also approved.
- The board meeting took place on August 4, 2026.
- Results pertain to the quarter ended June 30, 2026.
Price Impact
More from APLLTD